- Home
- INDP vs GXAI Comparison
INDP vs GXAI Comparison
Compare INDP & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- GXAI
- Stock Information
- Founded
- INDP 2000
- GXAI 2021
- Country
- INDP United States
- GXAI United States
- Employees
- INDP N/A
- GXAI N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- GXAI
- Sector
- INDP Health Care
- GXAI
- Exchange
- INDP Nasdaq
- GXAI Nasdaq
- Market Cap
- INDP 7.4M
- GXAI 7.3M
- IPO Year
- INDP N/A
- GXAI 2023
- Fundamental
- Price
- INDP $0.45
- GXAI $1.32
- Analyst Decision
- INDP Strong Buy
- GXAI
- Analyst Count
- INDP 2
- GXAI 0
- Target Price
- INDP $8.50
- GXAI N/A
- AVG Volume (30 Days)
- INDP 43.0K
- GXAI 97.7K
- Earning Date
- INDP 05-14-2025
- GXAI 05-27-2025
- Dividend Yield
- INDP N/A
- GXAI N/A
- EPS Growth
- INDP N/A
- GXAI N/A
- EPS
- INDP N/A
- GXAI N/A
- Revenue
- INDP N/A
- GXAI $27,740.00
- Revenue This Year
- INDP N/A
- GXAI N/A
- Revenue Next Year
- INDP N/A
- GXAI N/A
- P/E Ratio
- INDP N/A
- GXAI N/A
- Revenue Growth
- INDP N/A
- GXAI 1473.05
- 52 Week Low
- INDP $0.43
- GXAI $1.00
- 52 Week High
- INDP $3.10
- GXAI $7.50
- Technical
- Relative Strength Index (RSI)
- INDP 44.18
- GXAI 60.39
- Support Level
- INDP $0.36
- GXAI $1.07
- Resistance Level
- INDP $0.48
- GXAI $1.44
- Average True Range (ATR)
- INDP 0.05
- GXAI 0.08
- MACD
- INDP 0.01
- GXAI 0.03
- Stochastic Oscillator
- INDP 59.80
- GXAI 67.57
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.